|
|
||||||||
Viewpoint |
Center for Molecular Genetics, Department of Molecular Cardiology, Lerner Research Institute, The Cleveland Clinic Foundation, Cleveland, OH, 44195; Center for Cardiovascular Genetics, The Cleveland Clinic Foundation, Cleveland, OH, 44195
SUMMARY
Mutations in ion channels have been implicated in the formation of long QT syndrome (LQTS). However, Mohler et al. have recently uncovered a role for ankyrin-B, a non-ion channel protein, in type IV LQTS. Calcium signalling is altered, and the functions of several channels and pumps that normally interact with wild-type ankyrin-B are impaired in the presence of mutant ankyrin-B. The authors suggest that by disrupting the functions of these channels, a new mechanism has been uncovered that can lead to cardiac myopathy.
This article has been cited by other articles:
![]() |
Q Wang Author's reply: link of SCN5A SNP R1193Q to long QT syndrome J. Med. Genet., February 1, 2005; 42(2): e8 - e8. [Full Text] [PDF] |
||||
![]() |
C. Oberti, L. Wang, L. Li, J. Dong, S. Rao, W. Du, and Q. Wang Genome-Wide Linkage Scan Identifies a Novel Genetic Locus on Chromosome 5p13 for Neonatal Atrial Fibrillation Associated With Sudden Death and Variable Cardiomyopathy Circulation, December 21, 2004; 110(25): 3753 - 3759. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.R. K. Bhagavatula, C. Fan, G.-Q. Shen, J. Cassano, E. F. Plow, E. J. Topol, and Q. Wang Transcription factor MEF2A mutations in patients with coronary artery disease Hum. Mol. Genet., December 15, 2004; 13(24): 3181 - 3188. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ASPET Journals | Pharmacological Reviews | Drug Metabolism and Disposition |
| Molecular Interventions | Molecular Pharmacology | J Pharmacology and Exp Therapeutics |